Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3526 USD | +4.61% | +2.20% | +109.88% |
Apr. 02 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 | |
Apr. 01 | BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 19.05M | Sales 2025 * | 25.76M | Capitalization | 104M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | - | EV / Sales 2024 * | 5.48 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.05 x |
P/E ratio 2024 * |
-35.3
x | P/E ratio 2025 * |
-
| Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.77% |
Latest transcript on BioLargo, Inc.
1 day | +4.61% | ||
1 week | +2.20% | ||
Current month | +6.08% | ||
1 month | +8.49% | ||
3 months | +51.01% | ||
6 months | +120.38% | ||
Current year | +109.88% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Director of Finance/CFO | 68 | 08-01-31 | |
Chief Operating Officer | 55 | 02-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.3526 | +4.61% | 173,847 |
24-05-09 | 0.337 | -3.96% | 130,722 |
24-05-08 | 0.3509 | +0.29% | 128,455 |
24-05-07 | 0.3499 | -0.03% | 231,832 |
24-05-06 | 0.35 | +1.46% | 167,587 |
Delayed Quote OTC Markets, May 10, 2024 at 03:58 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+109.88% | 104M | |
+5.97% | 105B | |
-4.31% | 63.99B | |
+51.90% | 42.95B | |
+17.44% | 39.2B | |
+6.62% | 33.01B | |
+13.00% | 20.33B | |
+15.64% | 17.29B | |
+22.55% | 15.72B | |
+7.34% | 14.72B |
- Stock Market
- Equities
- BLGO Stock